Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025

ALLERGAN, INC. (AGN)

34
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on ALLERGAN, INC.
1h ago ALLERGAN : Ackman's Pershing Square raises $3 bln in fund listing
2d ago ALLERGAN : Valeant Pharmaceuticals' third-quarter sales to rise
2d ago ALLERGAN : Other Events, Financial Statements and Exhibits (form 8-K)
2d ago ALLERGAN : Announces FDA Approves Revised Indication for OZURDEX® (dexamethasone..
2d ago ALLERGAN : Board of Directors Issues Statement
3d ago ALLERGAN : Plastic Surgery Practice in Naples Awarded Allergan's Diamond Status
6d ago TSX tumbles to three-month low as sentiment sours
6d ago ALLERGAN : Issues Statement Regarding Recent Valeant Correspondence
6d ago ALLERGAN : Valeant pitches potential eye drug, research focus
7d ago ALLERGAN : Pershing Square, Valeant and Allergan Settle Pending Litigation Befor..
7d ago ALLERGAN : "Ophthalmic Compositions and Methods for Treating Eyes" in Patent App..
7d ago ALLERGAN : Patent Issued for Computer Analysis of a Breast Shape to Assist Breas..
7d ago ALLERGAN : to Hold Special Meeting of Stockholders on Originally Scheduled Date ..
7d ago ALLERGAN : Patent Issued for Compounds Having Analgesic And/Or Immunostimulant A..
7d ago ALLERGAN : Patent Application Titled "Preservative Free Bimatoprost and Timolol ..
7d ago ALLERGAN : Actress And TV Star Kyle Richards Diagnosed With A Type Of Chronic Dr..
7d ago S&P 500 MOVERS : Btu, bbby
7d ago ALLERGAN : Valeant Pharma expects 3Q revenue to top forecasts
7d ago Valeant CEO expects quarterly profit to exceed forecast
7d ago ACTAVIS IN BUYOUT TALKS WITH SALIX : Cnbc
7d ago ALLERGAN : Valeant Provides Update On Third Quarter Results And Sends Letter To ..
09/24 ALLERGAN : Assigned Patent
09/23 ALLERGAN : Write-Offs: 09.22.14
09/18 ALLERGAN : Actress And Tv Star Kyle Richards Diagnosed With A Type Of Chronic Dr..
09/18 ALLERGAN : to cut its workforce by 13%
09/18 ALLERGAN : Assigned Patent
09/17 ALLERGAN : Researchers Submit Patent Application, "Extended Release Biodegradabl..
09/17 ALLERGAN : Patent Application Titled "Compounds Act at Multiple Prostaglandin Re..
09/16 ALLERGAN : reaches truce with suitors on special shareholder meeting
09/16DJU.S. HOT STOCKS : Hot Stocks to Watch
09/16 ALLERGAN : agrees to move forward with meeting
09/16 ALLERGAN : Botox maker to slash 25 Irish posts
09/16 ALLERGAN : Botox job cuts ; companies today
09/16 ALLERGAN : Pershing Square, Valeant and Allergan Settle Pending Litigation Befor..
09/15 ALLERGAN : to Hold Special Meeting of Stockholders on Originally Scheduled Date ..
09/15 ALLERGAN : Pershing Square Submits Additional Special Meeting Requests
09/15 Ackman's Pershing Square plans $2 billion Amsterdam fund listing
09/12DJU.S. HOT STOCKS : Hot Stocks to Watch
09/12 ALLERGAN : Pershing Square Submits Additional Special Meeting Requests Represent..
09/11 ALLERGAN : Comments on Pershing Square's Delivery of Additional Requests from St..
09/11 ALLERGAN : Comments on Pershing Square's Delivery of Additional Requests from St..
09/11 ALLERGAN : Assigned Patent
09/10 ALLERGAN : Researchers Submit Patent Application, "Implantable Materials", for A..
09/10 ALLERGAN : Patent Issued for Directionless (Orientation Independent) Needle Inje..
09/10 ALLERGAN : Bill Ackman Can Start Writing His Victory Speech (Maybe)
09/10 ALLERGAN : Announces OZURDEX® dexamethasone 700 mcg intravitreal implant in appl..
09/09 ALLERGAN : Bill Ackman Thought Allergan Directors Would’ve Accepted The Fa..
09/09 WILLIAM ACKMAN : Ackman urges Allergan board to 'wake up' on Valeant talks
09/05 TSX steady as financials-led retreat offsets resource gains
09/05 ALLERGAN : Pershing Square Submits Requisite Requests from Allergan Shareholders..
09/04 ALLERGAN : to Request California Federal Court Block Valeant and Pershing Square..
09/04 ALLERGAN : Provides Update on Written Requests from Pershing Square Regarding Sp..
09/04 ALLERGAN : Patent Issued for N-(Imidazolidin-2-Ylidene)quinoline Derivatives as ..
09/04 ALLERGAN : Patent Application Titled "Sustained Drug Delivery Implant" Published..
09/04 ALLERGAN : "Sustained Drug Delivery Implant" in Patent Application Approval Proc..
09/04 ALLERGAN : Patent Application Titled "Pharmaceutical Compositions Comprising 4-B..
09/04 ALLERGAN : Assigned Patent
09/03 ALLERGAN : Files Answer in Federal Court Responding to Valeant and Pershing Squa..
09/02 ALLERGAN : U.S. court revives Botox-linked shareholder suit against Allergan
09/02 ALLERGAN : Files Answer in Federal Court Responding to Valeant and Pershing Squa..
09/02 ALLERGAN : Files Answer in Federal Court Responding to Valeant and Pershing Squa..
09/02 ALLERGAN : Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in app..
08/28 ALLERGAN : "Modular Injection System and Method for Diluting an Injectable Fluid..
08/28 ALLERGAN : Assigned Patent
08/28 ALLERGAN : Maryland Laser Skin and Vein Receives Diamond Status From Allergan
08/28 ALLERGAN : "Cross-Linked Hyaluronic Acid and Collagen and Uses Thereof" in Paten..
08/27 WILLIAM ACKMAN : Valeant, Ackman get October 6 trial over Allergan special meeti..
08/27 ALLERGAN : Taps Jim Hindman as CFO
08/26 ALLERGAN : Facing shareholder demands, Allergan calls special meeting for Decemb..
08/26 ALLERGAN : to Request California Federal Court Block Valeant and Pershing Square..
08/26 ALLERGAN : Eyes INR10bn Revenues By Fiscal 2018 In India
08/26 ALLERGAN : Latisse.md Announces 5.5 Million Latisse Bottles Sold
08/26 ALLERGAN : EYES Rs1,000 CRORE REVENUE
08/23 ALLERGAN : reviews meeting requests in takeover bid
08/22 WILLIAM ACKMAN : Ackman, other shareholders ask Allergan to call special meeting
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF